Off-label, Failure-to-Warn Preemption Cases May Head to Supreme Court
This article was originally published in The Gray Sheet
Executive Summary
While federal preemption of state suits for PMA-approved has been strongly validated by the Supreme Court, two types of plaintiffs' claims in particular offer the potential for the PMA preemption device to be considered once again by the high court, according to Mayer Brown partner Andrew Tauber.
You may also be interested in...
In Case You Missed It: Top 10 "Gray Sheet" Stories In September
Our most popular stories last month focused on tips from FDA experts on facility inspections, various legal trends, and Robert Califf's nomination to head FDA, among other topics.
Another Medtronic Preemption Case Appealed to High Court
A case questioning whether patients can sue device makers if a PMA-approved device is marketed for off-label uses may be headed to the Supreme Court, following a recent petition for a writ of certiorari.
Preemption Questions Persist: Supreme Court Doesn’t Take Bait In Medtronic Case
The Supreme Court’s decision not to take up Stengel v. Medtronic could make device firms vulnerable to more product liability suits by leaving open questions about the federal preemption defense for PMA-approved devices. Meanwhile, the Obama administration recently issued a legal interpretation that, if adopted, would surely weaken the defense.